Treatment of clozapine-associated weight gain: a systematic review. - Wikidata - awgldk - TriplyDB

Treatment of clozapine-associated weight gain: a systematic review.

Treatment of clozapine-associated weight gain: a systematic review.

http://www.wikidata.org/entity/Q38334922

about

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis An update of safety of clinically used atypical antipsychotics.Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.Clozapine-induced dysphagia with secondary substantial weight loss.Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX).Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review.Body and liver fat content and adipokines in schizophrenia: a magnetic resonance imaging and spectroscopy study.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics.Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis

P2860

Q30489980-95C5A8B0-AD51-4C8A-BAA0-0D8868E3ABAD Q34530975-3C7536A1-7323-417C-8273-AD1701363834 Q36062184-E9AAD3D0-8374-43A2-AF7F-687D57904F26 Q38708352-A5FD82AD-6250-41D9-AD4D-8D8B89C254A3 Q47280410-3974641D-5AEC-430D-BF46-DD41209F3821 Q47568761-5DBC71AB-4CB1-44D1-B92A-9BB59C46A6E0 Q47947938-170E5B7E-CDE3-4161-9795-877AAEBA6D54 Q52579281-A52D4812-6D98-497F-9AE3-2CED1CA43224 Q53118076-F6F570C4-E0A1-47BC-989C-93AEC4830688 Q55232340-B35EA603-15E3-4C71-843A-950DEEDAD755 Q55397191-67024E77-8176-488F-8269-35A2898E61A9 Q58791341-1F673FC6-AEB0-4302-BBFD-3ED4C83EFFCB

P2860

Treatment of clozapine-associated weight gain: a systematic review.

http://www.wikidata.org/entity/Q38334922

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Treatment of clozapine-associated weight gain: a systematic review.

@en

type

label

Treatment of clozapine-associated weight gain: a systematic review.

@en

prefLabel

Treatment of clozapine-associated weight gain: a systematic review.

@en

P1433

Q38334922-FC840525-9BFD-4F63-994C-6895D7CCEA20

P1476

Q38334922-B9525A20-9857-45AF-943D-BE5FD43EBBE6

P2093

Q38334922-29BD4C04-5C6D-44B5-AEEB-F5B4D52516DB

Q38334922-F1928828-203C-43F1-9223-8C141C48C010

P2860

Q38334922-060398DA-0EE9-406A-970F-49E2CF84AAB7

Q38334922-100B43B7-9180-4BDB-B06B-6CD55590A1F3

Q38334922-116F1227-6E2B-47E8-BE46-19D949316D16

Q38334922-131EC520-E5ED-498C-A6D3-06208C76549F

Q38334922-24968D22-560B-48C0-8B8A-79F4AF6BD6F8

Q38334922-27572D83-6887-45AC-86FF-E803AAE30F2A

Q38334922-29531BF3-F5D5-4C50-974D-D1E01D878EBB

Q38334922-2FD0B08A-7FE6-454D-9CF3-10C98D9F919C

Q38334922-303C6F4F-81B8-4B44-94DD-BB751C7A5E4C

Q38334922-37DB5E5E-99A4-47B6-97B5-0F2CE549F3C1

P2888

Q38334922-F816389A-9D3A-4114-BC6F-23A4441EB489

P304

Q38334922-DB8DEC0A-7E3E-43FD-9635-A513933FF72F

P31

Q38334922-E286B2C9-5401-4AE2-A2D4-0667ABC493E4

P356

Q38334922-8321F97F-BCB0-4D80-A49C-5C0E1BF18D96

P433

Q38334922-4E3C1C06-0E92-422D-B61F-B4FC084C369B

P478

Q38334922-823B40D1-04C3-4BC8-A82F-6ACF296D6C12

P50

Q38334922-860E4D49-2DDA-41C3-B110-06692443F3E6

Q38334922-AFCFB945-90D4-4B25-B0A4-7FDA9BCB483F

P577

Q38334922-EA9DDAD8-ED32-45B7-A13F-5276D7109C2F

P5875

Q38334922-FA5A9DB6-4D5B-414C-9883-0EB5998395D8

P6179

Q38334922-208A88EB-D3BF-4173-A9A4-B3B5FCEE185D

P698

Q38334922-4A79E97F-4891-4F58-8DF9-3CAE8745731B

P921

Q38334922-80D363D5-A7E4-44B7-973F-11DFF142DE31

P356

S00228-015-1807-1

P1433

European Journal of Clinical Pharmacology

P1476

Treatment of clozapine-associated weight gain: a systematic review

@en

P2093

D H Fredrikson

http://www.w3.org/2001/XMLSchema#string

Z Whitney

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of the prevalence of schizophrenia.

Second-generation antipsychotics and extrapyramidal adverse effects

Approved and investigational uses of modafinil : an evidence-based review

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial.

A history of antipsychotic drug development.

Pharmacological actions of the atypical antipsychotic drug clozapine: a review.

Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.

Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.

Topiramate-induced weight loss: a review.

P2888

s00228-015-1807-1

P304

389-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-015-1807-1

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Ric M Procyshyn

Alasdair M Barr

P577

2015-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271599518

http://www.w3.org/2001/XMLSchema#string

P6179

1033627189

http://www.w3.org/2001/XMLSchema#string

P698

25627831

http://www.w3.org/2001/XMLSchema#string

P921